Prelude Capital Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Buy |
765
+108
| +16% | +$33.9K | 0.02% | 718 |
|
|
2025
Q1 | $200K | Buy |
657
+33
| +5% | +$10.1K | 0.02% | 861 |
|
|
2024
Q4 | $207K | Sell |
624
-583
| -48% | -$194K | 0.01% | 853 |
|
|
2024
Q3 | $403K | Buy |
1,207
+236
| +24% | +$78.8K | 0.02% | 638 |
|
|
2024
Q2 | $400K | Sell |
971
-369
| -28% | -$152K | 0.03% | 577 |
|
|
2024
Q1 | $542K | Buy |
1,340
+571
| +74% | +$231K | 0.03% | 541 |
|
|
2023
Q4 | $236K | Sell |
769
-1,080
| -58% | -$331K | 0.02% | 742 |
|
|
2023
Q3 | $448K | Sell |
1,849
-8,506
| -82% | -$2.06M | 0.03% | 414 |
|
|
2023
Q2 | $2.49M | Buy |
10,355
+2,072
| +25% | +$498K | 0.16% | 139 |
|
|
2023
Q1 | $1.56M | Buy |
8,283
+222
| +3% | +$41.7K | 0.09% | 230 |
|
|
2022
Q4 | $1.71M | Buy |
8,061
+195
| +2% | +$41.4K | 0.09% | 221 |
|
|
2022
Q3 | $1.24M | Buy |
+7,866
| New | +$1.24M | 0.04% | 349 |
|
|
2022
Q2 | – | Sell |
-4,800
| Closed | -$785K | – | 1713 |
|
|
2022
Q1 | $785K | Buy |
+4,800
| New | +$785K | 0.02% | 530 |
|
|
2020
Q4 | – | Sell |
-46
| Closed | -$5K | – | 1244 |
|
|
2020
Q3 | $5K | Buy |
+46
| New | +$5K | ﹤0.01% | 1173 |
|
|
2019
Q2 | – | Sell |
-209
| Closed | -$12K | – | 1522 |
|
|
2019
Q1 | $12K | Sell |
209
-3,145
| -94% | -$181K | ﹤0.01% | 1027 |
|
|
2018
Q4 | $178K | Buy |
3,354
+2,300
| +218% | +$122K | 0.01% | 535 |
|
|
2018
Q3 | $63K | Sell |
1,054
-446
| -30% | -$26.7K | ﹤0.01% | 771 |
|
|
2018
Q2 | $65K | Buy |
+1,500
| New | +$65K | ﹤0.01% | 833 |
|
|
2018
Q1 | – | Sell |
-3,693
| Closed | -$134K | – | 1475 |
|
|
2017
Q4 | $134K | Hold |
3,693
| – | – | 0.01% | 636 |
|
|
2017
Q3 | $118K | Sell |
3,693
-800
| -18% | -$25.6K | 0.01% | 761 |
|
|
2017
Q2 | $130K | Buy |
4,493
+2,993
| +200% | +$86.6K | 0.01% | 641 |
|
|
2017
Q1 | $45K | Buy |
+1,500
| New | +$45K | ﹤0.01% | 966 |
|